Organization: McGill Univ

CMC Microsystems opens second collaboratory centre

CMC Microsystems has officially opened the second of four specialized laboratories that comprise the $23-million National Microelectronics and Photonics Testing Collaboratory. Located in Winnipeg at the Univ of Manitoba, the $1.9-million Advanced RF Systems Laboratory will be accessible to researchers across Canada and beyond over CA*net 4, the high-speed research network owned and operated by…

GrowthWorks invests $9.5 million in high-tech firms

GrowthWorks Canadian Fund is investing $9.5 million in three high-technology firms. The latest investments are in: Advanced Glazings Ltd ($2.5 million), Sydney NS, a manufacturer of insulated glass units; SaskAlta Base Oils Corp ($2 million), Calgary, which recovers and refines hydrocarbon resources from feedstock; and, Viron Therapeutics Inc, London ON ($5 million), an early stage…

Mimetogen Pharmaceuticals receives series A financing

McGill Univ spinoff Mimetogen Pharmaceuticals Inc has received series A financing from a venture capital consortium led by Boston-based VIMAC Milestone Medica Fund. Also participating is original investor MSBi Capital, a seed and early-stage fund created to commercialize technologies from McGill, Univ of Sherbrooke and Bishop’s Univ. Mimetogen is currently developing therapeutic approaches for small…

Tenrox receives $4.6 million in VC from Novacap Inc

Tenrox Inc has received $4.6 million from Novacap Inc, a Longueuil PQ-based private equity and venture capital firm to further develop its Microsoft-based software for the tracking and accounting of business projects and processes. In 2003, Tenrox overhauled its product offering, moving from client-server to web-based applications. At that time, Tenrox moved its corporate headquarters…

NSERC and PAPRICAN fund two industrial chairs

Pulp and paper researchers at McGill Univ will benefit from the creation of two new industrial research chairs with $3 million over five years from Science and Engineering Research Canada (NSERC) and the Pulp and Paper Research Institute of Canada (PAPRICAN). Each organization is providing $1.5 million, while PAPRICAN is contributing in-kind resources for the…

Chronogen finalizes licensing deal with McGill

Montreal-based Chronogen Inc has secured an exclusive worldwide licence from McGill Univ for screening assays for targets and drugs used in the treatment and prevention of lipid disorder linked to atherosclerosis. The licensed technology, which expands Chronogen’s IP portfolio in the field of aging and age-related diseases, is based on discoveries made by Dr Siegfried…

MSBI invests $650,000 in new start-up firm

MSBI Capital has invested $650,000 in CarboPur Technologies Inc, a start-up firm founded on the research of Dr Jean-Pierre Farant at McGill Univ’s department of occupational health. CarboPur is commercializing a high density activated carbon felt with a low-cost manufacturing process and patented regeneration technology. Targeted applications include air and water filtration. The Montreal-based firm…

NSERC provides funding to photonics research network

The Natural Sciences and Engineering Research Council (NSERC) has announced funding for a new broadband research network. NSERC will provide $7 million over five years to the Agile All-Photonics Research Network (AAPN), that permits the capacity of entire national networks to be transmitted over a single fibre. Nearly $1 million and in-kind support was provided…

NSERC expands Northern Research Chairs program

The Natural Sciences and Engineering Research Council (NSERC) has expanded its Northern Research Chairs program with the announcement of an additional $6.1 million to fund six new chairs. The chairs will be located at Carleton Univ, McGill Univ, Univ of Manitoba, Univ of Alberta, Univ of Laval and Wilfred Laurier Univ. They will focus their…

Researchers make muscular dystrophy breakthrough

Researchers at McGill Univ and the Univ of Manitoba have discovered a gene responsible for limb-girdle muscular dystrophy, characterized by muscle weakness in the pelvis and shoulders. The breakthrough is considered critical, as the research findings are broadly applicable to research on all other forms of muscular dystrophy. It is also seen as an important…